ORBIMED ADVISORS LLC
Related Filers (312)
- ISALY SAMUEL D (214)
- OrbiMed Capital GP VI LLC (110)
- OrbiMed Capital GP IV LLC (80)
- OrbiMed Capital GP V LLC (76)
- OrbiMed Capital GP III LLC (74)
- OrbiMed Genesis GP LLC (73)
- OrbiMed Capital GP VII LLC (69)
- ORBIMED CAPITAL LLC (59)
- Galecto, Inc. (35)
- Anthera Pharmaceuticals Inc (28)
- Xtant Medical Holdings, Inc. (28)
- Alector, Inc. (27)
- OrbiMed Advisors Israel II Ltd (24)
- OrbiMed Israel GP II, L.P. (24)
- INTERCEPT PHARMACEUTICALS INC (23)
- Corvus Pharmaceuticals, Inc. (22)
- NxStage Medical, Inc. (21)
- ViewRay, Inc. (21)
- AMARIN CORP PLC\UK (20)
- ALPINE IMMUNE SCIENCES, INC. (19)
- Relypsa Inc (18)
- Sorrento Tech, Inc. (17)
- Disc Medicine, Inc. (17)
- SpringWorks Therapeutics, Inc. (17)
- OrbiMed Capital GP VIII LLC (17)
- ORTHOVITA INC (16)
- ORBIMED CAPITAL GP II LLC (16)
- PIERIS PHARMACEUTICALS, INC. (16)
- Ascendis Pharma A/S (16)
- DEPOMED INC (15)
- ATHERSYS, INC / NEW (15)
- Passage BIO, Inc. (15)
- Sierra Oncology, Inc. (14)
- Adicet Bio, Inc. (14)
- Kala Pharmaceuticals, Inc. (14)
- GIVEN IMAGING LTD (13)
- AFFYMETRIX INC (13)
- LIFECELL CORP (13)
- Biodel Inc (13)
- Inspire Medical Systems, Inc. (13)
- Theseus Pharmaceuticals, Inc. (13)
- Orbimed ROF II LLC (13)
- Kinnate Biopharma Inc. (13)
- Loxo Oncology, Inc. (12)
- OTONOMY, INC. (12)
- Adaptimmune Therapeutics PLC (12)
- GLAUKOS Corp (12)
- Arcutis Biotherapeutics, Inc. (12)
- Oric Pharmaceuticals, Inc. (12)
- BIOMARIN PHARMACEUTICAL INC (11)
- NPS PHARMACEUTICALS INC (11)
- Pacira Pharmaceuticals, Inc. (11)
- SYNLOGIC, INC. (11)
- Compass Therapeutics, Inc. (11)
- ARRAY BIOPHARMA INC (10)
- AVANIR PHARMACEUTICALS, INC. (10)
- SUPERNUS PHARMACEUTICALS INC (10)
- X4 Pharmaceuticals, Inc (10)
- 89bio, Inc. (10)
- Tricida, Inc. (10)
- Ikena Oncology, Inc. (10)
- DISCOVERY LABORATORIES INC /DE/ (9)
- ONYX PHARMACEUTICALS INC (9)
- ACCELRYS, INC. (9)
- INSULET CORP (9)
- INFINITY PHARMACEUTICALS, INC. (9)
- Sientra, Inc. (9)
- SELECTA BIOSCIENCES INC (9)
- Affimed N.V. (9)
- scPharmaceuticals Inc. (9)
- RHYTHM PHARMACEUTICALS, INC. (9)
- Aeglea BioTherapeutics, Inc. (9)
- FLUIDIGM CORP (9)
- Repare Therapeutics Inc. (9)
- PMV Pharmaceuticals, Inc. (9)
- Verona Pharma plc (9)
- NeuroPace Inc (9)
- DOV PHARMACEUTICAL INC (8)
- EXELIXIS INC (8)
- ARYx Therapeutics, Inc. (8)
- 3SBio Inc. (8)
- INTERMUNE INC (8)
- Audentes Therapeutics, Inc. (8)
- SteadyMed Ltd. (8)
- RESPONSE BIOMEDICAL CORP (8)
- Aadi Bioscience, Inc. (8)
- Prelude Therapeutics Inc (8)
- Edgewise Therapeutics, Inc. (8)
- Enliven Therapeutics, Inc. (8)
- Terns Pharmaceuticals, Inc. (8)
- TELA Bio, Inc. (8)
- ENZON PHARMACEUTICALS INC (7)
- ARQULE INC (7)
- GEN PROBE INC (7)
- CRYOCOR INC (7)
- ARIAD PHARMACEUTICALS INC (7)
- COMPLETE GENOMICS INC (7)
- Mirati Therapeutics, Inc. (7)
- CTI BIOPHARMA CORP (7)
- IMMUNOMEDICS INC (7)
- Show More ...
Other (150)
13F-HR
Wednesday, 2/14/2024
Initial Quarterly Form 13F Holdings Report filed by institutional managers
144
Wednesday, 12/27/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 12/27/2023
Filing for proposed sale of securities under Rule 144
144/A
Friday, 12/15/2023
Filing for proposed sale of securities under Rule 144
144/A
Friday, 12/15/2023
Filing for proposed sale of securities under Rule 144
144/A
Friday, 12/15/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 12/12/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 12/12/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 12/12/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 11/22/2023
Filing for proposed sale of securities under Rule 144
13F-HR
Tuesday, 11/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
144
Monday, 10/2/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 10/2/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 10/2/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 8/30/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 8/30/2023
Filing for proposed sale of securities under Rule 144
144/A
Monday, 8/21/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 8/21/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 8/21/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 8/15/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 8/15/2023
Filing for proposed sale of securities under Rule 144
13F-HR
Monday, 8/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
144
Monday, 7/31/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 7/31/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 7/25/2023
Filing for proposed sale of securities under Rule 144
144
Tuesday, 7/25/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 7/13/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 7/13/2023
Filing for proposed sale of securities under Rule 144
144
Thursday, 6/15/2023
Filing for proposed sale of securities under Rule 144
13F-HR
Monday, 5/15/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
144
Thursday, 5/11/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 4/19/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 4/10/2023
Filing for proposed sale of securities under Rule 144
144
Monday, 4/10/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 4/5/2023
Filing for proposed sale of securities under Rule 144
144
Wednesday, 4/5/2023
Filing for proposed sale of securities under Rule 144
13F-HR
Tuesday, 2/14/2023
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/15/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/16/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 2/14/2022
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/15/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/16/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/17/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/16/2021
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/16/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 8/14/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 5/15/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
144
Thursday, 4/9/2020
Filing for proposed sale of securities under Rule 144
144
Thursday, 4/9/2020
Filing for proposed sale of securities under Rule 144
144
Monday, 3/30/2020
Filing for proposed sale of securities under Rule 144
144
Monday, 3/30/2020
Filing for proposed sale of securities under Rule 144
144
Tuesday, 3/24/2020
Filing for proposed sale of securities under Rule 144
144
Tuesday, 3/24/2020
Filing for proposed sale of securities under Rule 144
13F-HR
Friday, 2/14/2020
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 11/14/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 8/14/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 5/15/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 2/14/2019
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 11/14/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 8/14/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 5/15/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 2/14/2018
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 11/14/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/14/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/15/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/14/2017
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/14/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/15/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/16/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/16/2016
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR/A
Wednesday, 11/18/2015
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 11/13/2015
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR/A
Thursday, 8/20/2015
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 8/14/2015
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 5/15/2015
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 2/13/2015
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 11/14/2014
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 8/14/2014
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 5/15/2014
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Friday, 2/14/2014
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 11/14/2013
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 8/14/2013
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 5/15/2013
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR/A
Wednesday, 4/17/2013
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR/A
Friday, 2/22/2013
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Thursday, 2/14/2013
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR/A
Thursday, 12/13/2012
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Wednesday, 11/14/2012
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 8/14/2012
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 5/15/2012
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Tuesday, 2/14/2012
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR/A
Wednesday, 11/23/2011
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/14/2011
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/15/2011
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/16/2011
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 2/14/2011
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 11/15/2010
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 8/16/2010
Initial Quarterly Form 13F Holdings Report filed by institutional managers
13F-HR
Monday, 5/17/2010
Initial Quarterly Form 13F Holdings Report filed by institutional managers
Ownership (1676)
SC 13G/A
Wednesday, 2/14/2024
Applied Therapeutics Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Mereo BioPharma Group plc: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
X4 Pharmaceuticals, Inc: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Verastem, Inc.: Major Shareholders
SC 13G
Wednesday, 2/14/2024
Elevation Oncology, Inc.: Major Shareholders
4
Wednesday, 2/14/2024
Theseus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13G/A
Wednesday, 2/14/2024
Mersana Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Crinetics Pharmaceuticals, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
SI-BONE, Inc.: Major Shareholders
SC 13G
Wednesday, 2/14/2024
InspireMD, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Kezar Life Sciences, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
Protara Therapeutics, Inc.: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
ALX ONCOLOGY HOLDINGS INC: Major Shareholders
SC 13G
Wednesday, 2/14/2024
Scholar Rock Holding Corp: Major Shareholders
SC 13G/A
Wednesday, 2/14/2024
NeuroPace Inc: Major Shareholders
SC 13D
Monday, 2/5/2024
ArriVent Biopharma, Inc.: Major Shareholders
SC 13D/A
Monday, 2/5/2024
CalciMedica, Inc.: Major Shareholders
4
Wednesday, 1/31/2024
ArriVent Biopharma, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 1/29/2024
Adicet Bio, Inc.: Major Shareholders
4
Friday, 1/26/2024
Adicet Bio, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 1/25/2024
Edgewise Therapeutics, Inc.: Major Shareholders
4
Thursday, 1/25/2024
Edgewise Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
3
Thursday, 1/25/2024
ArriVent Biopharma, Inc.: Initial statement of beneficial ownership of securities
4
Tuesday, 1/16/2024
ALPINE IMMUNE SCIENCES, INC.: Statement of changes in beneficial ownership of securities
4
Friday, 12/29/2023
ALPINE IMMUNE SCIENCES, INC.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 12/29/2023
ALPINE IMMUNE SCIENCES, INC.: Major Shareholders
SC 13D/A
Wednesday, 12/27/2023
Theseus Pharmaceuticals, Inc.: Major Shareholders
4
Wednesday, 12/20/2023
Disc Medicine, Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 12/15/2023
Disc Medicine, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 12/15/2023
Disc Medicine, Inc.: Major Shareholders
4
Thursday, 12/14/2023
Disc Medicine, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 12/13/2023
Keros Therapeutics, Inc.: Major Shareholders
SC 13D/A
Wednesday, 12/6/2023
SpringWorks Therapeutics, Inc.: Major Shareholders
SC 13D/A
Wednesday, 11/29/2023
Apollomics Inc.: Major Shareholders
SC 13D/A
Friday, 11/24/2023
Theseus Pharmaceuticals, Inc.: Major Shareholders
4
Friday, 11/24/2023
PMV Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 11/20/2023
Apollomics Inc.: Major Shareholders
SC 13D/A
Friday, 11/17/2023
Kinnate Biopharma Inc.: Major Shareholders
SC 13D/A
Tuesday, 11/14/2023
Kinnate Biopharma Inc.: Major Shareholders
SC 13D/A
Monday, 11/13/2023
ALPINE IMMUNE SCIENCES, INC.: Major Shareholders
SC 13D/A
Wednesday, 11/1/2023
Apollomics Inc.: Major Shareholders
SC 13D/A
Wednesday, 10/4/2023
SYNLOGIC, INC.: Major Shareholders
4
Wednesday, 10/4/2023
NeuroPace Inc: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 10/2/2023
Apollomics Inc.: Major Shareholders
4/A
Thursday, 9/21/2023
Ikena Oncology, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 9/21/2023
Ikena Oncology, Inc.: Major Shareholders
SC 13D/A
Monday, 9/18/2023
Galecto, Inc.: Major Shareholders
4
Thursday, 9/14/2023
Ikena Oncology, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 9/14/2023
Ikena Oncology, Inc.: Major Shareholders
SC 13D/A
Tuesday, 9/5/2023
Galecto, Inc.: Major Shareholders
4
Thursday, 8/31/2023
ARS Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 8/23/2023
PMV Pharmaceuticals, Inc.: Major Shareholders
4
Thursday, 8/17/2023
Galecto, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 8/17/2023
Galecto, Inc.: Major Shareholders
SC 13D/A
Friday, 8/11/2023
Gracell Biotechnologies Inc.: Major Shareholders
SC 13D/A
Thursday, 8/3/2023
Xtant Medical Holdings, Inc.: Major Shareholders
4
Wednesday, 8/2/2023
Galecto, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 8/2/2023
Galecto, Inc.: Major Shareholders
4
Thursday, 7/27/2023
Galecto, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Monday, 7/24/2023
Turnstone Biologics Corp.: Major Shareholders
4
Monday, 7/24/2023
Turnstone Biologics Corp.: Statement of changes in beneficial ownership of securities
3
Thursday, 7/20/2023
Turnstone Biologics Corp.: Initial statement of beneficial ownership of securities
4
Wednesday, 7/19/2023
Theseus Pharmaceuticals, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 7/19/2023
Theseus Pharmaceuticals, Inc.: Major Shareholders
4
Monday, 7/17/2023
Galecto, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 7/17/2023
Galecto, Inc.: Major Shareholders
SC 13D/A
Thursday, 6/29/2023
Passage BIO, Inc.: Major Shareholders
4
Thursday, 6/29/2023
Passage BIO, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Thursday, 6/29/2023
Adicet Bio, Inc.: Major Shareholders
4
Thursday, 6/29/2023
Adicet Bio, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 6/21/2023
Disc Medicine, Inc.: Major Shareholders
4
Wednesday, 5/24/2023
Prelude Therapeutics Inc: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 5/24/2023
Prelude Therapeutics Inc: Major Shareholders
SC 13D
Wednesday, 5/24/2023
VectivBio Holding AG: Major Shareholders
4
Friday, 5/19/2023
Enliven Therapeutics, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Wednesday, 5/17/2023
SpringWorks Therapeutics, Inc.: Major Shareholders
SC 13D/A
Tuesday, 5/16/2023
Fusion Pharmaceuticals Inc.: Major Shareholders
SC 13D/A
Tuesday, 5/16/2023
Verona Pharma plc: Major Shareholders
4
Monday, 5/15/2023
Verona Pharma plc: Statement of changes in beneficial ownership of securities
4
Monday, 5/8/2023
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Monday, 5/8/2023
Kinnate Biopharma Inc.: Major Shareholders
SC 13D/A
Friday, 5/5/2023
Xtant Medical Holdings, Inc.: Major Shareholders
SC 13D/A
Wednesday, 5/3/2023
Kinnate Biopharma Inc.: Major Shareholders
4
Tuesday, 5/2/2023
Kinnate Biopharma Inc.: Statement of changes in beneficial ownership of securities
4
Friday, 4/21/2023
TELA Bio, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 4/21/2023
TELA Bio, Inc.: Major Shareholders
4
Monday, 4/17/2023
Galecto, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Wednesday, 4/12/2023
Apollomics Inc.: Major Shareholders
4
Wednesday, 4/12/2023
Galecto, Inc.: Statement of changes in beneficial ownership of securities
SC 13D/A
Friday, 4/7/2023
Galecto, Inc.: Major Shareholders
4
Friday, 4/7/2023
Galecto, Inc.: Statement of changes in beneficial ownership of securities
SC 13D
Friday, 3/31/2023
Gracell Biotechnologies Inc.: Major Shareholders
SC 13D/A
Wednesday, 3/29/2023
Terns Pharmaceuticals, Inc.: Major Shareholders
SC 13D/A
Friday, 3/24/2023
89bio, Inc.: Major Shareholders
SC 13D/A
Friday, 3/24/2023
CalciMedica, Inc.: Major Shareholders
SC 13D/A
Wednesday, 3/22/2023
CalciMedica Inc: Major Shareholders
SC 13D/A
Tuesday, 3/14/2023
Theseus Pharmaceuticals, Inc.: Major Shareholders
SC 13D
Tuesday, 2/28/2023
Enliven Therapeutics, Inc.: Major Shareholders
SC 13D/A
Tuesday, 2/28/2023
Fusion Pharmaceuticals Inc.: Major Shareholders
4
Monday, 2/27/2023
Enliven Therapeutics, Inc.: Statement of changes in beneficial ownership of securities